COR Cencora, Inc.
$306.92
Cencora, Inc. (COR) is expected to report earnings on November 2, 2026, before the market open. The consensus earnings estimate is $4.51 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.9% since its last earnings release on August 5, 2026.
Cencora Beat Consensus Estimates, Raises Earnings Guidance, but Reamins In-line with Estimates
Wednesday, August 5, 2026 · 6:30 AM ET
Earnings Date
4th Quarter, Sep 2026
Nov 2
Monday · 6:30 AM ET
Earnings Whisper
-
vs $4.51
Rev est $88.09B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$320.59
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Cencora, Inc.
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world.
Sector
Healthcare
Industry
Drugs Wholesale
Held By 10 ETFs, by dollar flow
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- RTH VanEck Retail ETF
- RTH VanEck Retail ETF
- IYK iShares U.S. Consumer Staples ETF
- IYK iShares U.S. Consumer Staples ETF
- PPH VanEck Pharmaceutical ETF
- PPH VanEck Pharmaceutical ETF
Charts powered in part by Lightweight Charts™ by TradingView.